Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and Physicians
CLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM Software Inc., a leading global provider of medical imaging software, announced U.S. Food and Drug Administration (FDA) clearance of its newest AI auto-contouring solution, Contour ProtégéAI+™.
New Zero-Click AI Auto-Contouring Solution Gives Cancer Treatment Planners More Time for Plan Evaluation
Unlike other auto-contouring tools, Contour ProtégéAI+ requires no clicks. Contouring of lymph node level and OAR structures starts automatically, and no manual intervention is required to launch. Results are exported directly to the TPS or MIM for review. This gives dosimetrists and physicians more time to create quality treatment plans for their patients.
“Cancer treatment planning teams should have as much time as possible to focus on developing precise, individualized treatment plans,” said Jay Obman, Product Manager at MIM Software Inc. “The MIM team is thrilled that zero-click auto-contouring of lymph node level and OAR structures with Contour ProtégéAI+ will save clinicians the time-consuming manual effort that comes with other auto-contouring tools.”
Learn more about Contour ProtégéAI+.
About MIM Software Inc.
MIM Software Inc. is a privately held company headquartered in Cleveland, OH, with international offices in Beijing, Chengdu, and Brussels.
MIM Software sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies. The company’s products are used in over 3,500 centers worldwide.
MIM Software is committed to enhancing patient care by providing customer-centered and innovative imaging solutions in the fields of Radiation Oncology, Radiology, Nuclear Medicine, Theranostics, Interventional Radiology, and Urology.
Contact Information
Bill Carruthers
Product Marketing Manager
bcarruthers@mimsoftware.com
216-455-0610
Jim Janek
Director of Marketing
jjanek@mimsoftware.com
440-212-4455
Related Files
mim softare logo.png
contour-protegeai-plus_logo.png
SOURCE: MIM Software Inc.
View source version on accesswire.com:
https://www.accesswire.com/812891/mim-software-inc-announces-fda-clearance-of-contour-protgai
DUBLIN--(BUSINESS WIRE)--The "Global Medical Device Connectivity Market: Analysis By Product & Services, By Technology, By…
VANCOUVER, WA / ACCESSWIRE / March 22, 2024 / At just eight years old, Zeke…
GOTHENBURG, SWEDEN / ACCESSWIRE / March 22, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB…
OCALA, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or…
WALTHAM, Mass., March 22, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a…
Poster presentation delivers pre-clinical results that demonstrate that its lead development product, Telomir-1, elongates telomere…